promegestone has been researched along with Adenocarcinoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajalovic, N; Lin, VCL; Tan, S; Wong, ESP | 1 |
| Sampath, D; Winneker, RC; Zhang, Z | 1 |
| Chao, V; Dreher, E; Mueller, MD; Pritts, EA; Taylor, RN; Vigne, JL | 1 |
| Al-Dhaheri, M; Faber, LE; Pang, H; Rowan, BG | 1 |
| Chen, CL; Liao, QP; Lu, Y; Yu, L | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Tremblay, RR; Tremblay, Y | 1 |
| Fujioka, H; Kotake, T; Matsuda, M; Nakano, E; Osafune, M; Sato, B; Sonoda, T; Tada, Y; Takaha, M | 1 |
| Bonneterre, J; Dewailly, D; Hecquet, B; Lefebvre, J; Peyrat, JP; Vandewalle, B | 1 |
| Chaichik, S; Chen, L; Keydar, I; Weiss, FR | 1 |
| Ferenczy, A; Shyamala, G | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 1 |
| Becker, M; Sheldon, LA; Smith, CL | 1 |
| Bojar, H; Maar, K; Staib, W | 3 |
| Dahlberg, E; Ekman, P; Gustafsson, JA; Snochowski, M | 1 |
| Hata, H; Kuramoto, H | 1 |
| Kokai, Y; Lyttle, CR; Modiano, JF; Nowell, PC; Pykett, MJ; Weiner, DB | 1 |
| Aakvaag, A; Eskild, W; Hansson, V; Jahnsen, T; Lahooti, H; Landmark, BF; Levy, FO; Ree, AH | 1 |
| Brocic, M; Kanazir, D; Milasin, J; Ribarac-Stepic, N; Sulovic, V | 1 |
| Johnson, IE; Mobbs, BG | 1 |
21 other study(ies) available for promegestone and Adenocarcinoma
| Article | Year |
|---|---|
Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells.
Topics: Adenocarcinoma; Autophagosomes; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Lysosomes; MCF-7 Cells; Microtubule-Associated Proteins; Neoplasm Proteins; Promegestone; Protein Interaction Mapping; Protein Transport; Receptors, Progesterone; Recombinant Proteins; Signal Transduction; Transcriptional Activation | 2019 |
The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth.
Topics: Adenocarcinoma; Antibodies; Breast Neoplasms; Cell Division; Cysteine-Rich Protein 61; Drug Synergism; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Neovascularization, Pathologic; Progesterone Congeners; Promegestone; S Phase; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Up-Regulation | 2002 |
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Medroxyprogesterone; Mifepristone; Promegestone; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Size; Cytoskeletal Proteins; Desmoplakins; Epidermal Growth Factor; Female; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Promegestone; S Phase | 2004 |
[Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Topics: Adenocarcinoma; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estradiol; Female; Humans; Mifepristone; Oligodeoxyribonucleotides, Antisense; Promegestone; Receptors, Progesterone; Transfection | 2006 |
Single case report of prostate adenocarcinoma in a dog castrated three months previously. Morphological, biochemical, and endocrine determinations.
Topics: Adenocarcinoma; Animals; Castration; Cell Nucleus; Cytosol; Disease Models, Animal; Dogs; Estradiol; Estrenes; Male; Metribolone; Promegestone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Steroid; Testosterone Congeners; Time Factors | 1984 |
Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy.
Topics: Adenocarcinoma; Aged; Estradiol; Estrenes; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Metribolone; Middle Aged; Promegestone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Testosterone | 1984 |
Nuclear estradiol-binding sites in human breast cancer.
Topics: Adenocarcinoma; Binding, Competitive; Breast Neoplasms; Cell Nucleus; Estradiol; Female; Humans; Kinetics; Promegestone; Receptors, Estradiol; Receptors, Estrogen | 1983 |
Steroid receptors in human renal carcinoma.
Topics: Adenocarcinoma; Aged; Cytosol; Dexamethasone; Diethylstilbestrol; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Promegestone; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Testosterone | 1980 |
The effect of sodium molybdate on the cytoplasmic estrogen and progesterone receptors in human endometrial tissues.
Topics: Adenocarcinoma; Adult; Aged; Centrifugation, Density Gradient; Culture Techniques; Endometrium; Estradiol; Female; Humans; Middle Aged; Molybdenum; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1981 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Steroid hormone receptor-mediated histone deacetylation and transcription at the mouse mammary tumor virus promoter.
Topics: Adenocarcinoma; Animals; Cell Nucleus; Chromatin; Dexamethasone; Glucocorticoids; Histones; Kinetics; Mammary Tumor Virus, Mouse; Mice; Progestins; Promegestone; Promoter Regions, Genetic; Receptors, Steroid; Terminal Repeat Sequences; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosol.
Topics: Adenocarcinoma; Centrifugation, Density Gradient; Cytosol; Humans; Kidney Neoplasms; Middle Aged; Neoplasms, Hormone-Dependent; Norpregnadienes; Promegestone; Radioligand Assay; Receptors, Cell Surface | 1979 |
The endocrine background of human renal cell carcinoma. II. Attempt to induce the R-5020-binding components by oestrogens.
Topics: Adenocarcinoma; Aged; Cytosol; Estrogens; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Norpregnadienes; Promegestone; Receptors, Cell Surface; Receptors, Progesterone | 1979 |
Steroid receptors in metastatic carcinoma of the human prostate.
Topics: Adenocarcinoma; Aged; Cytosol; Dexamethasone; Humans; Isoelectric Focusing; Lymphatic Metastasis; Male; Middle Aged; Promegestone; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid | 1979 |
The endocrine background of human renal cell carcinoma. III. Role of inhibitors of R 5020 binding in tumour cytosol.
Topics: Adenocarcinoma; Cytosol; Female; Humans; In Vitro Techniques; Kidney Neoplasms; Male; Norpregnadienes; Promegestone; Receptors, Steroid | 1979 |
Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells).
Topics: Adenocarcinoma; Animals; Cell Nucleus; Endometrial Neoplasms; Estradiol; Female; Immunohistochemistry; Promegestone; Rats; Receptors, Estrogen; Receptors, Progesterone; Staining and Labeling; Tumor Cells, Cultured | 1992 |
Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Cat Diseases; Cats; Cell Division; DNA Replication; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Animal; Mifepristone; Neoplasms, Hormone-Dependent; Phosphorylation; Progesterone; Progestins; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured | 1991 |
Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Line; Dose-Response Relationship, Drug; Estradiol; Humans; Immunologic Techniques; Osmolar Concentration; Promegestone; Proteins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Time Factors | 1989 |
Sex steroid receptors in transformed human cervical tissue.
Topics: Adenocarcinoma; Adult; Cellulose; DNA; Estradiol; Female; Humans; Middle Aged; Papilloma; Polyps; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Uterine Cervical Diseases; Uterine Cervical Dysplasia; Uterine Cervical Erosion; Uterine Cervical Neoplasms | 1986 |
Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
Topics: Adenocarcinoma; Animals; Binding, Competitive; Centrifugation, Density Gradient; Cytosol; Diethylstilbestrol; Estrenes; Male; Metribolone; Norpregnadienes; Promegestone; Prostatic Neoplasms; Rats; Receptors, Progesterone | 1985 |